Understand the source comparison
SS-LUP-332 Endurance Results Timeline Expect: Research vs Performance Use
Typical Timeline to Observable Effect 14–21 days (mitochondrial markers); 28 days (functional endurance) Unknown. No human trials exist Research timelines reflect optimal dosing, controlled conditions, and young healthy models; real-world variability would be
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Typical Timeline to Observable Effect
- 14–21 days (mitochondrial markers); 28 days (functional endurance)
- Unknown. No human trials exist
- Research timelines reflect optimal dosing, controlled conditions, and young healthy models; real-world variability would be higher
- Dose Consistency
- Daily administration at precise mg/kg, verified by plasma sampling
- Uncontrolled. Self-administration introduces variability
- Missed doses or inconsistent timing would extend timeline significantly
- Baseline Conditioning
- Sedentary controls or structured training protocols with known intensity
- Highly variable. Training status unknown
- Trained individuals likely show blunted response; sedentary show larger absolute gains but longer timeline
- Monitoring Method
- Direct VO₂ measurement, treadmill exhaustion tests, tissue biopsy for mitochondrial density
- Subjective performance perception, indirect markers
- Without objective measurement, early-phase adaptations would be undetectable
- Safety Oversight
- Veterinary monitoring, histopathology, adverse event tracking
- None. Compound not approved for human use
- Unknown toxicity profile in humans; timeline could be interrupted by side effects
- Regulatory Status
- Research-only compound under institutional oversight
- Illegal for human consumption; not FDA-approved
- Use outside controlled research violates federal law and poses unquantified health risks